Data / Form D filings / Aditxt, Inc.
Aditxt, Inc.: Form D filings
Aditxt, Inc., a biotechnology company in Richmond, VA, filed 6 Form D notices with the SEC between 2018 and 2024. The latest, on January 23, 2024, reports $6 million sold of a $6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 737 N. FIFTH STREET, SUITE 200, Richmond, VA, 23219
- Phone
- (650) 870-1200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1726711
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | New notice | $6,000,000 | $6,000,000 | 1 | Dec 29, 2023 | sec.gov | |
| Sep 20, 2023 | New notice | $10,000,000 | $10,000,000 | 1 | Sep 6, 2023 | sec.gov | |
| Aug 17, 2022 | New notice | $2,200,000 | $2,033,333 | $166,667 | 6 | Aug 4, 2022 | sec.gov |
| Jan 26, 2021 | New notice | $6,000,000 | $6,000,000 | 1 | Jan 25, 2021 | sec.gov | |
| Dec 26, 2018 | New notice | $2,000,000 | $109,800 | $1,890,200 | 4 | Nov 27, 2018 | sec.gov |
| Mar 29, 2018 | New notice | $2,000,000 | $262,500 | $1,737,500 | 8 | Mar 17, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rowena Albanna | Executive Officer | |
| Amro Albanna | Executive Officer, Director | |
| Shahrokh Shabahang | Executive Officer, Director | |
| Corinne Pankovcin | Executive Officer | |
| Brian Brady | Director | |
| Charles Athle Nelson | Director | |
| Jeffrey Runge | Director | |
| Thomas Farley | Executive Officer |
Other biotechnology companies in Virginia that filed recently
- GENHEALTH, INC. $16.5 million · Sep 29, 2026
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Jan 22, 2024 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aditxt, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.